HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief

This article was originally published in The Rose Sheet

Executive Summary

Perfumania will acquire all of Parlux’s outstanding shares under a Dec. 23 merger agreement, L’Oreal to open a research and innovation center, more.

You may also be interested in...



Lonza Launches Vivillume For Skin Luminosity, Under-Eye Circles

Aimed at improving skin’s luminosity and overall radiance, Lonza Personal Care introduces new active Vivillume at in-cosmetics Barcelona. Ingredient is derived from the seeds of the White Bird of Paradise flower, and helps to improve skin tone and decrease under-eye circles and puffiness.

Parlux Ad Blitz Behind Rihanna To Pay Off As Scent Unrolls Globally

Parlux Fragrances is filling out its business with designer licenses and international expansion while enjoying early signs of record-breaking success at the department-store level with Rihanna Reb’l Fleur.

Inter Parfums Eagerly Anticipates Burberry Body, Brand’s Largest-Ever Launch

New York-based Inter Parfums recorded a 6.8% decrease in earnings for its fiscal 2011 second quarter, but looks to the upcoming launch of Burberry Body to jumpstart its performance for the year.

Related Content

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017901

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel